Testing effectiveness (Phase 2)WithdrawnNCT02367690
What this trial is testing
Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients
Who this might be right for
Diabetic Foot Ulcers
Karyopharm Therapeutics Inc